These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15111546)

  • 1. The case for intravenous arginine stimulation in lieu of mixed-meal tolerance tests as outcome measure for intervention studies in recent-onset type 1 diabetes.
    Greenbaum C; Seidel K; Pihoker C
    Diabetes Care; 2004 May; 27(5):1202-4. PubMed ID: 15111546
    [No Abstract]   [Full Text] [Related]  

  • 2. Postprandial glucose, insulin and incretin responses to different carbohydrate tolerance tests.
    Deng Y; Zhang Y; Zheng S; Hong J; Wang C; Liu T; Sun Z; Gu W; Gu Y; Shi J; Yao S; Wang W; Ning G
    J Diabetes; 2015 Nov; 7(6):820-9. PubMed ID: 25395350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes.
    Gredal C; Rosenfalck AM; Dejgaard A; Hilsted J
    Scand J Clin Lab Invest; 2007; 67(3):327-36. PubMed ID: 17454847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine-metabolic function in remission-phase IDDM during administration of cyclosporine.
    Dupre J; Jenner MR; Mahon JL; Purdon C; Rodger NW; Stiller CR
    Diabetes; 1991 May; 40(5):598-604. PubMed ID: 2022304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of human fetal pancreas transplantation on secretion of C-peptide and glucose tolerance in type I diabetics.
    Robertson RP; Lafferty KJ; Haug CE; Weil R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2354-6. PubMed ID: 3274519
    [No Abstract]   [Full Text] [Related]  

  • 6. [2h-CPR/2h-PG in 75g-OGTT].
    Onouchi Z; Kunimaru S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():394-9. PubMed ID: 15779411
    [No Abstract]   [Full Text] [Related]  

  • 7. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
    Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
    Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of beta cell function in type 1 diabetes mellitus.
    Vendrame F; Zappaterreno A; Dotta F
    Minerva Med; 2004 Apr; 95(2):79-84. PubMed ID: 15272242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulated urine C-peptide creatinine ratio vs serum C-peptide level for monitoring of β-cell function in the first year after diagnosis of Type 1 diabetes.
    Tatovic D; Luzio S; Dunseath G; Liu Y; Alhadj Ali M; Peakman M; Dayan CM;
    Diabet Med; 2016 Nov; 33(11):1564-1568. PubMed ID: 27425010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
    Vilsbøll T; Toft-Nielsen MB; Krarup T; Madsbad S; Dinesen B; Holst JJ
    Diabetes Care; 2000 Jun; 23(6):807-12. PubMed ID: 10841001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-peptide response to oral glucose.
    Carpenter MA
    Age Ageing; 1992 Nov; 21(6):463. PubMed ID: 1471586
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-peptide secretion during the remission phase of juvenile diabetes.
    Heinze E; Beischer W; Keller L; Winkler G; Teller WM; Pfeiffer EF
    Diabetes; 1978 Jun; 27(6):670-6. PubMed ID: 350677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
    Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S
    Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent measures of insulin secretion and insulin sensitivity during the same test: the glucagon-insulin tolerance test.
    Dorkhan M; Tripathy D; Malm G; Asgharian H; Tuomi T; Groop L
    J Intern Med; 2008 Jul; 264(1):62-71. PubMed ID: 18298489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory unit of islet transplant objects (SUITO) index can predict outcome of intravenous glucose tolerance test.
    Takita M; Matsumoto S; Noguchi H; Shimoda M; Chujo D; Itoh T; Sugimoto K; Tamura Y; Olsen GS; Naziruddin B; Onaca N; Levy MF
    Transplant Proc; 2010; 42(6):2065-7. PubMed ID: 20692409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum C-peptide content in nutritional diabetes.
    Ahuja MM; Sharma GP
    Horm Metab Res; 1985 May; 17(5):267-8. PubMed ID: 4007780
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathophysiology of beta cell failure after prolonged remission of insulin-dependent diabetes mellitus (IDDM).
    Drucker D; Zinman B
    Diabetes Care; 1984; 7(1):83-7. PubMed ID: 6423354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on: Besser et al. Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes. Diabetes Care 2013;36:195-201.
    Chaudhary S; Thukral A; Kataria M; Ghosh S; Mukherjee S; Chowdhury S
    Diabetes Care; 2013 Dec; 36(12):e221. PubMed ID: 24265390
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to comment on: Besser et al. Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes. Diabetes Care 2013;36:195-201.
    Shields BM; Henley W; Besser RE; Hattersley AT; Ludvigsson J
    Diabetes Care; 2013 Dec; 36(12):e222. PubMed ID: 24265391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.